ACTR-41. INTERIM RESULTS OF FIRST-IN-HUMAN STUDY USING NATIVIS VOYAGER™ SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

BACKGROUND: The Nativis Voyager® ulRFE™ system, a non-invasive investigational device, was studied in a first-in-human feasibility study to assess safety and feasibility of the treatment for recurrent glioblastoma (GBM). The anti-mitotic therapy delivers ultra-low radio frequency energy (ulRFE) prod...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Barkhoudarian, Garni, Cobbs, Charles, McClay, Edward, Vaillant, Brian, Duic, J Paul, Nabors, Burt, Ellingson, Benjamin, Sheffield, Deborah, Kesari, Santosh
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693000/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.032
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares